SOX4 and SMARCA4 upregulate glycolysis-driven tumor proliferation through Hexokinase 2 in Triple Negative Breast Cancer.

被引：0
|
作者：
Khanna, Pooja [1 ]
Mehta, Gaurav [1 ]
Bhatt, Vrushank [1 ]
Guo, Jessie Y. [1 ]
Gatza, Michael L. [1 ]
机构：
[1] CINJ, New Brunswick, NJ USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-035
引用
收藏
页数：1
相关论文
共 45 条
  • [31] ASH2L plays a role in triple-negative breast cancer cells through the control of histone H3 lysine 4 methylation
    Ishimura, Akihiko
    Terashima, Minoru
    Takino, Takahisa
    Suzuki, Takeshi
    CANCER SCIENCE, 2024, 115 : 226 - 226
  • [32] B4GALNT2 Gene Promotes Proliferation, and Invasiveness and Migration Abilities of Model Triple Negative Breast Cancer (TNBC) Cells by Interacting With HLA-B Protein
    Yu, Pu
    Zhu, Lili
    Cui, Kang
    Du, Yabing
    Zhang, Chaojie
    Ma, Wang
    Guo, Jia
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [33] Histone demethylase KDM2B promotes triple negative breast cancer proliferation by suppressing p15INK4B, p16INK4A and p57KIP2 transcription
    Zheng, Qingping
    Fan, Hongjia
    Meng, Zhenzhen
    Yuan, Lin
    Liu, Cuicui
    Peng, You
    Zhao, Weiwei
    Wang, Lulu
    Li, Jing
    Feng, Jing
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2018, 50 (09) : 897 - 904
  • [34] Co-stimulation through 4-1BB/CD137 improves expansion and function of tumor-infiltrating T lymphocytes from primary and metastatic triple-negative breast cancer and inflammatory breast cancer
    Harao, Michiko
    Gao, Hui
    Chen, Jie Qing
    Mittendorf, Elizabeth A.
    Babiera, Gildy V.
    DeSnyder, Sarah M.
    Rockwood, Korrene F.
    Krishnamurthy, Savitri
    Sun, Huiming
    Willey, Jie S.
    Ueno, Naoto T.
    Reuben, James M.
    Radvanyi, Laszlo G.
    CANCER RESEARCH, 2015, 75
  • [35] MORF4L2 induces immunosuppressive microenvironment and immunotherapy resistance through GRHL2/MORF4L2/H4K12Ac/CSF1 axis in triple-negative breast cancer
    Sui, Xin-Yi
    Cao, Shuo-Wen
    Song, Xiao-Qing
    Liu, Xi-Yu
    Chen, Chao
    Yan, Qingya
    Wang, Zhi-Qing
    Zhang, Wen-Juan
    Ma, Lin-Xiaoxi
    Jin, Xi
    Ma, Ding
    Xiao, Yi
    Wu, Song-Yang
    Xu, Ying
    Shao, Zhi-Ming
    Fan, Lei
    BIOMARKER RESEARCH, 2025, 13 (01)
  • [36] Targeting Delta-Like 4 Ligand (DLL4)/Notch Signaling by a Novel Anti-DLL4 Antibody Inhibits Tumor Growth through Altering Cancer Stem Cell and Epithelial-to-Mesenchymal Transition-Associated Genes in Triple Negative Breast Cancer
    Yen, W-C
    Fischer, M.
    Beviglia, L.
    Yeung, P.
    Kapoun, A.
    Wang, M.
    Lewicki, J.
    Gurney, A.
    Hoey, T.
    CANCER RESEARCH, 2010, 70
  • [37] Fibroblast Growth Factor Receptor 4 Promotes Triple-Negative Breast Cancer Progression via Regulating Fatty Acid Metabolism Through the AKT/RYR2 Signaling
    Ye, Jinhui
    Wu, Song
    Quan, Qiang
    Ye, Feng
    Zhang, Jinhui
    Song, Cailu
    Fan, Yidan
    Cao, Huijiao
    Tang, Hailin
    Zhao, Jianfu
    CANCER MEDICINE, 2024, 13 (23):
  • [38] AIbZIP/CREB3L4 Promotes Cell Proliferation via the SKP2-p27 Axis in Luminal Androgen Receptor Subtype Triple-Negative Breast Cancer
    Ito, Taichi
    Saito, Atsushi
    Kamikawa, Yasunao
    Nakazawa, Nayuta
    Imaizumi, Kazunori
    MOLECULAR CANCER RESEARCH, 2024, 22 (04) : 373 - 385
  • [39] MORF4L2 induces immunosuppressive microenvironment and immunotherapy resistance through GRHL2/MORF4L2/H4K12Ac/CSF1 axis in triple-negative breast cancer (vol 13, 6, 2025)
    Sui, Xin-Yi
    Cao, Shuo-Wen
    Song, Xiao-Qing
    Liu, Xi-Yu
    Chen, Chao
    Yan, Qingya
    Wang, Zhi-Qing
    Zhang, Wen-Juan
    Ma, Lin-Xiaoxi
    Jin, Xi
    Ma, Ding
    Xiao, Yi
    Wu, Song-Yang
    Xu, Ying
    Shao, Zhi-Ming
    Fan, Lei
    BIOMARKER RESEARCH, 2025, 13 (01)
  • [40] Oncometabolite D-2HG drives tumor metastasis and protumoral macrophage polarization by targeting FTO/m6A/ANGPTL4/integrin axis in triple-negative breast cancer
    Zhang, Siyue
    Zhang, Ning
    Wan, Tong
    He, Yinqiao
    Hao, Jie
    Liu, Yiwei
    Liu, Yidong
    Chen, Bing
    Zhao, Wenjing
    Wang, Lijuan
    Luo, Dan
    Gao, Chao
    Yang, Qifeng
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2025, 44 (01)
12345